Study of the effect of formulation variables on the characteristics of combination tablets containing enalapril maleate and indapamide as active substances using experimental design

Abstract

Study of the effect of formulation variables on the characteristics of combination tablets containing enalapril maleate and indapamide as active substances using experimental designTo evaluate the influence of different variables on tablet formulations containing enalapril maleate and indapamide as active substances, two separate experimental designs were employed: one for evaluating powder properties and the other for tablet characteristics. Because of the low active pharmaceutical ingredient content, it was hypothesized that both powder and tablet properties could be determined only by the characteristics of excipients. In order to test this assumption, both experimental designs were done with placebo mixtures. The optimized formulation was then evaluated both with and without APIs. Results indicated that filler and lubricant percentage, along with compression force, were the most important variables during the formulation study. The optimized formulation showed similar characteristics in both cases for all responses, except for angle of repose and friability where only minor differences were observed. The combination of the applied approaches (using placebo composition and fractional experimental design) proved to be efficient, cost effective and time saving.Keywords: design of experiments, optimization, factorial design, placebo formulation Proper management of hypertension, one of the leading causes of cardiovascular disease, is of the utmost importance. It has been established that lowering of blood pressure can effectively reduce the risk of cardiovascular events and stroke, but finding the most appropriate therapy is often difficult (1). Combinational therapies employing an angiotensin-converting enzyme inhibitor (ACEi) and indapamide (IND) offer the advantage of using two highly effective agents, increasing both clinical efficiency and patient compliance (2-4). Low dose combinations of ACEis and diuretics have shown greater reduction in blood pressure and higher success rates in managing hypertension than either of the treatments alone (4-6). The most popular ACEis present in these combinations include perin- Szabo et al.: Study of the effect of formulation variables on the characteristics of combination tablets containing enalapril maleate and indapamide as active substances using experimental design, Acta Pharm. 66 (2016) 191-206.

HPLC method development for fampridine using Analytical Quality by Design approach

“…Based on the results of these experiments the optimal run conditions can be statistically determined and the outcome of unperformed experiments predicted with high accuracy (21). Pharmaceutical applications of DoE include the development and optimization of single-component (22,23) and multi-component formulations (24,25), as well as the development and validation of analytical methods (26,27).…”

Reversed phase HPLC for strontium ranelate: Method development and validation applying experimental design

“…The up-to-date "quality by design" approach has been successfully used in the pharmaceutical development and characterisation of tablets, optimization of tablet formulations (12,13) and also for the analytical method development and validation of HPLC (14,15) and other analytical methods (16). Design of experiments (DoE) has many advantages in pharmaceutical drug formulations and analytical method development and validation in comparison with techniques like changing one factor at a time (COST).…”

Quality-by-design in pharmaceutical development: From current perspectives to practical applications

“…Compression force, as one should expect, would define tablet hardness and API dissolution from the tablets' matrix, whereas the optimum turret and feeder rotation speed ratio define the mass uniformity. Szabo et al (66) investigated the effect of formulation variables on the manufacturability of tablets containing a combination of enalapril maleate and indapamide. In their study, microcrystalline cellulose, croscarmellose sodium and magnesium stearate had a noticeable impact on manufacturability and in-process control of tablets, while compression force was noted as the most influential process parameter on product performance characteristics.…”